ClearPath Diagnostics2019-02-15T22:00:59+00:00

Project Description

ClearPath Diagnostics

ClearPath_port500x300

DOWNLOAD THE CASE STUDY (PDF)

In October 2016 Shore announced the sale of ClearPath Diagnostics (“ClearPath”), a leading provider of laboratory diagnostic services in the Northeastern United States, to Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH), the world’s leading healthcare diagnostics company. Together, Shore Capital and ClearPath executed a growth strategy that extended the company’s geographic reach to four states and expanded the service menu to include new cutting-edge tests. The growth was driven by organic initiatives as ClearPath expanded the sales force from one professional to a team of nine highly trained business development experts and implemented LEAN processes that ensured best-in-class turnaround times.

Headquarters

Syracuse, NY

Sector

Laboratory Services

With Shore Since

September 2011

Exited

October 2016

Independent Board Members

Key Shore Contact